Skip to main content
Premium Trial:

Request an Annual Quote

Collin D Silva Resigns as CEO of Transgenomic; Remains Board Chairman

NEW YORK, April 4 (GenomeWeb News) - Collin D'Silva has resigned as chief executive officer of Transgenomic, the company said yesterday.

 

Michael Summers, the company's chief financial officer, has taken over as interim CEO until a new chief executive has been found. He also remains CFO.

 

D'Silva will remain chairman of the board of directors. He will manage strategic customer relationships and evaluate corporate strategic alternatives.

 

A company spokesperson did not cite a reason why D'Silva stepped down as CEO.

The Scan

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.

Gut Microbiomes Allow Bears to Grow to Similar Sizes Despite Differing Diets

Researchers in Scientific Reports find that the makeup of brown bears' gut microbiomes allows them to reach similar sizes even when feasting on different foods.

Finding Safe Harbor in the Human Genome

In Genome Biology, researchers present a new approach to identify genomic safe harbors where transgenes can be expressed without affecting host cell function.

New Data Point to Nuanced Relationship Between Major Depression, Bipolar Disorder

Lund University researchers in JAMA Psychiatry uncover overlapping genetic liabilities for major depression and bipolar disorder.